tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Higgins, 99 are a BUY (95.19%), 5 are a HOLD (4.81%).
Analyst Michael Higgins, currently employed at LADENBURG, carries an average stock price target met ratio of 34.48% that have a potential upside of 33.16% achieved within 214 days.
Michael Higgins’s has documented 195 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRNS, Marinus Pharmaceuticals at 14-Aug-2024.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 5/14/2020. The price target of $50 was fulfilled within 4 days with a profit of $11.7 (30.55%) receiving and performance score of 76.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Sep-2024
$13
$6.51 (100.31%)
$13
4 months 8 days ago
(23-Jun-2026)
0/4 (0%)
$7.99 (159.48%)
Buy Since 21-Aug-2025
$12
$5.98 (99.34%)
$12
4 months 9 days ago
(22-Jun-2026)
0/5 (0%)
$6.9 (135.29%)
Buy Since 23-Jun-2021
$11
$4.98 (82.72%)
$11
1 years 10 months 27 days ago
(04-Dec-2024)
0/7 (0%)
$6.47 (142.83%)
Buy Since 16-Apr-2024
$20
$13.98 (232.23%)
$20
2 years 21 days ago
(10-Oct-2024)
0/3 (0%)
$15.05 (304.04%)
Buy Since 17-Sep-2020
$11
$4.51 (69.49%)
$19
2 years 7 months 26 days ago
(05-Mar-2024)
0/5 (0%)
$6.61 (150.57%)
What Year was the first public recommendation made by Michael Higgins?
